✦ LIBER ✦

A controlled-trial of house dust mite eradication using natamycin in homes of patients with atopic dermatitis

✍ Scribed by C.F.H. Vickers

Book ID: 108661842
Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 47 KB
Volume: 122
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.1990.tb08296.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Exposure to house dust mites in homes of

Exposure to house dust mites in homes of people with atopic dermatitis

✍ M.J. COLLOFF 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB

Double-blind placebo-controlled house du

Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis

✍ C. Gutgesell; S. Heise; S. Seubert; A. Seubert; S. Domhof; E. Brunner; C. Neuman 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 400 KB

Effect of house dust mite avoidance meas

Effect of house dust mite avoidance measures in children with atopic dermatitis

✍ G. Ricci; A. Patrizi; F. Specchia; L. Menna; P. Bottau; V. D’Angelo; M. Masi 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB

## Background: House dust mite allergens are associated with atopic dermatitis (ad). ## Objectives: The aim of our study was to verify if house dust mite allergen avoidance measures can improve the clinical manifestations of ad in children. ## Methods: Forty-one children (mean age 3.9 years) af

A double-blind controlled trial of hypos

A double-blind controlled trial of hyposensitization to the house dust mite in childhood atopic eczema

✍ M.T. GLOVER; D.J. ATHERTON 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Effects of pimecrolimus cream 1% in the

Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial

✍ D.Y.M. Leung; J.M. Hanifin; D.M. Pariser; K.A. Barber; R.G. Langley; P.M. Schlie 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

Efficacy and safety of topical WBI-1001

Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial

✍ R. Bissonnette; Y. Poulin; Y. Zhou; J. Tan; H.C. Hong; J. Webster; W. Ip; L. Tan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB